USCAP 2012 Annual Meeting

USCAP 2012 Annual Meeting

The 101st annual meeting of the USCAP was held in Vancouver, British Columbia, Canada, on March 17 – 23, 2012. Considered the world’s largest gathering of physician pathologists each year, we were able to participate in an historical learning experience. The Department of Pathology participated in paper and poster submissions, as well as Dr. Saul Suster lecturing on Mediastinal Tumors: A Practical Approach with Dr. Cesar Moran of MD Anderson.

The department of pathology is also pleased to have had the opportunity to participate in USCAP-TV. Though the number of spots were limited, our department was offered the chance to showcase our best practices and new ventures. The 5 minute film, as well as posters presented at the conference, are available below.


Watch in a New Window

Poster Submissions

Blast Immunophenotypes by Flow Cytometry in Acute Myeloid Leukemia With Myelodysplasia-Related Changes
CD200 Expresion in Non-Myeloma Immunoproliferative Disorders
Comparison of Progranostic Receptors in Primary Breast Cancer and Nodal Metastases
Cribriform Adenocarcinoma of the Lung: Clinicopathologic, Immunohistochemical and Molecular Study of 15 Cases

Cribriform Adenocarcinoma of the Lung: Clinicopathologic, Immunohistochemical and Molecular Study of 15 Cases

Authors: Arturo Luévano, MD | Nagarjun Rao, MD | Alexander Mackinnon, MD, PhD | Saul Suster, MD
Department of Pathology, Clinical and Translational Research Core Lab, Medical College of Wisconsin, Milwaukee, WI

More ›

Cutaneous CD30+ Lymphoproliferative Disorder With CD8 Expression. A Clinicopathological Study of 19 Cases

Cutaneous CD30+ Lymphoproliferative Disorder With CD8 Expression. A Clinicopathological Study of 19 Cases

Authors: Jose A. Plaza, MD | Andrew Feldman, MD | Cynthia Magro, MD
Department of Dermatopathology, Weill Cornell Medical Medical College, New York, NY, Mayo Clinic, Rochester, Rochester, MN, and the Medical College of Wisconsin, Milwaukee, WI

More ›

Diagnostic Utility and Comparative Immunohistochemical Analysis of MITF and SOX10 in Melanoma InSitu: A Clinicopathological and Immunohistochemical Study of 50 Cases

Diagnostic Utility and Comparative Immunohistochemical Analysis of MITF and SOX10 in Melanoma InSitu: A Clinicopathological and Immunohistochemical Study of 50 Cases

Authors: J. Noelle Buonaccorsi, MD | Saul Suster, MD | Victor G. Prieto, MD, PhD | Jose A. Plaza, MD Department... More ›

Flow Cystometric Blast Immunophenotypes in Acute Myeloid Leukemias Arising from Non-Acute Myeloid Disorders

Flow Cystometric Blast Immunophenotypes in Acute Myeloid Leukemias Arising from Non-Acute Myeloid Disorders

Authors: James Vaughan, MD | Horatiu Olteanu, MD, PhD | Steven H. Kroft, MD | Alexandra M. Harrington MD Department of... More ›

The Incidence of CD56 Expression by Flow Cytometry in Acute Promyelocytic Leukemia in Patients Treated With All-Trans Retinoic Acid and Anthracycline Drug Combinations

The Incidence of CD56 Expression by Flow Cytometry in Acute Promyelocytic Leukemia in Patients Treated With All-Trans Retinoic Acid and Anthracycline Drug Combinations

Authors: Horatiu Olteanu, MD, PhD | Alexandra M. Harrington MD | Steven H. Kroft, MD Department of Pathology, Medical College of... More ›

Megakaryocytic Hyperplasia Associated with Granulocyte Colony Stimulating Factor

Megakaryocytic Hyperplasia Associated with Granulocyte Colony Stimulating Factor

Authors: Lauren N. Parsons, MD | Horatiu Olteanu, MD, PhD | Steven H. Kroft, MD | Alexandra M. Harrington MD Department... More ›

Morphologic Changes in Myelodysplastic Syndrome Treated With Hypomethylating Agents
Most Diffuse Large B-cell Lymphomas are Identified by Flow Cytometry
Pathologic Response to Neoadjuvant Radiotherapy (NRT) as Potential Prognostic Factor in Soft Tissue Sarcomas (SFS)

Pathologic Response to Neoadjuvant Radiotherapy (NRT) as Potential Prognostic Factor in Soft Tissue Sarcomas (SFS)

Authors: Jason C. Chang, MD1 | David L. Stockman, MD1 | Meena Bedi, MD2 | Dian Wang, MD2 | Eduardo V. Zambrano, MD1

1Department of Pathology and 2Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI

More ›

The Presence of Residual Normal Peripheral Blood B-Cells in Newly Diagnosed Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (CLL/SLL) Identifies a Good Prognostic Subgroup